QYR Market Research Global Low Molecular Weight Heparin Market | Página 4

QYResearch
• The global consumption of low molecular weight heparin increases from 12.47
tonne in 2012 to 16.85 tonne in 2016, at a CAGR of more than 7.82%. In 2016, in
term of volume, the global Low molecular weight heparin market is led by Europe,
capturing about 35.25% of global low molecular weight heparin consumption.
USA is the second’s largest market with the share of 33.08%.
PPT模板下载：www.1ppt.com/moban/
节日PPT模板：www.1ppt.com/jieri/
PPT背景图片：www.1ppt.com/beijing/
优秀PPT下载：www.1ppt.com/xiazai/
Word教程： www.1ppt.com/word/
资料下载：www.1ppt.com/ziliao/
范文下载：www.1ppt.com/fanwen/
教案下载：www.1ppt.com/jiaoan/
字体下载：www.1ppt.com/ziti/
行业PPT模板：www.1ppt.com/hangye/
PPT素材下载：www.1ppt.com/sucai/
PPT图表下载：www.1ppt.com/tubiao/
PPT教程： www.1ppt.com/powerpoint/
Excel教程：www.1ppt.com/excel/
PPT课件下载：www.1ppt.com/kejian/
试卷下载：www.1ppt.com/shiti/
• China is a big low molecular weight heparin production country, especially
Heparin API, but it is not strong country. According to our research and analysis,
manufacturers from United States and Europe are the major leaders in the
international market of low molecular weight heparin. Manufacturers from China
are immature in technology. There is large space in the China market, as well as
big gap between international brands and local brands on price.
Click to view the full report TOC, figure and tables：
https://www.qyresearch.com/index/detail/482070/global-
low-molecular-weight-heparin-market